Dr. Daniel Gallego-Perez and team awarded over $230K for research

Posted: 

BME assistant professor Daniel Gallego-Perez and his research team has been awarded over $230,000 for two years by the National Institute of Neurological Disorders and Stroke. Dr. Gallego-Perez’s research is titled “Nanotechnology-based non-viral derivation of induced endothelium for ischemic disorders."

The project will focus on the development of novel cell therapies based nanotechnology-enabled non-viral cell reprogramming. Direct cell reprogramming has the potential to facilitate the implementation of safer and more effective patient-specific cell therapies. Current reprogramming methodologies, however, face major practical and translational hurdles. The proposed research aims to overcome these barriers by devising innovative nanotechnological approaches for deriving functional endothelium via direct reprogramming, which could potentially be used in pro-angiogenic therapies for a number of ischemic disorders.

Congratulations, Dr. Gallego-Perez!